| 1 |
35072549 | The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. | 2022 Mar |
1 |
| 2 |
35104687 | A common TMPRSS2 variant has a protective effect against severe COVID-19. | 2022 May |
1 |
| 3 |
35412356 | Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19. | 2022 Apr 27 |
1 |
| 4 |
33176395 | Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety. | 2021 Feb |
1 |
| 5 |
33505639 | Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2. | 2021 |
1 |
| 6 |
33647240 | Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions. | 2021 Apr 1 |
1 |
| 7 |
33676899 | Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. | 2021 Mar |
1 |
| 8 |
33750821 | Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2. | 2021 Mar 9 |
1 |
| 9 |
33903855 | Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. | 2021 May |
2 |
| 10 |
33996911 | Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2. | 2021 |
1 |
| 11 |
34075338 | Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach. | 2021 |
2 |
| 12 |
34100014 | Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease. | 2021 Aug 12 |
2 |
| 13 |
34406858 | Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease. | 2021 Oct 13 |
2 |
| 14 |
34692233 | Dual inhibition of TMPRSS2 and Cathepsin Bprevents SARS-CoV-2 infection in iPS cells. | 2021 Dec 3 |
1 |
| 15 |
34787160 | Targeting mechanism for SARS-CoV-2 in silico: interaction and key groups of TMPRSS2 toward four potential drugs. | 2021 Nov 25 |
2 |
| 16 |
32595355 | Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target. | 2020 |
1 |
| 17 |
32664879 | New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. | 2020 Jul 15 |
1 |
| 18 |
32741259 | Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies. | 2020 Aug 3 |
1 |
| 19 |
32793911 | Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. | 2020 Aug 5 |
2 |